EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo

Xinyu Liu, Wenjing Li, Licheng Xu, Xiaoxue Chen, Rui Zhao, Yan Guo, Jingchun Ge, Zhenming Yang, Liang Li, Jiarui Zhang, Jing Cao, Yue Shao und 3 weitere

The International Journal of Biochemistry & Cell Biology · 2023

DOI: 10.1016/j.biocel.2023.106398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2023. Verfasst von Xinyu Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Carcinoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although surgery is an important treatment for laryngeal cancer, surgery has a significant negative impact on the quality of life of patients, and many patients have poor tolerance to surgery. Therefore, alternative chemotherapeutic drugs are an important research hotspot. Chidamide is a histone deacetylase inhibitor that selectively inhibits the expression of type I and IIb histone deacetylases (1, 2, 3 and 10). It has a significant anticancer effect on a variety of solid tumours. This study verified the inhibitory effect of chidamide on laryngeal carcinoma. We conducted a variety of cellular and animal experiments to explore how chidamide inhibits the development of laryngeal cancer. The results showed that chidamide had significant antitumour activity against laryngeal carcinoma cells and xenografts and could induce cell apoptosis, ferroptosis and pyroptosis. This study provides a potential option for the treatment of laryngeal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal NeoplasmsCarcinomaAnimalsHumansHistone Deacetylase InhibitorsCell ProliferationQuality of LifeCell Line, TumorAminopyridinesApoptosisBenzamides

Stichwörter der Autor:innen

ApoptosisChidamideFerroptosisLaryngeal cancerPyroptosis

Substanzen

Histone Deacetylase InhibitorsAminopyridinesN-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamideBenzamides

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Department of Otorhinolaryngology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Department of Otorhinolaryngology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: tianlinli78@163.com.
  • Department of Otorhinolaryngology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: liuming_harbin@126.com.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Heilongjiang Province

Zitieren

APA

Liu, X., Li, W., Xu, L., Chen, X., Zhao, R., Guo, Y., Ge, J., Yang, Z., Li, L., Zhang, J., Cao, J., Shao, Y., Guo, X., Tian, L., & Liu, M. (2023). Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2023.106398

Vancouver

Liu X, Li W, Xu L, Chen X, Zhao R, Guo Y, et al. Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo. The International Journal of Biochemistry & Cell Biology. 2023. doi:10.1016/j.biocel.2023.106398

BibTeX
@article{Liu2023,
  author = {Liu, Xinyu and Li, Wenjing and Xu, Licheng and Chen, Xiaoxue and Zhao, Rui and Guo, Yan and Ge, Jingchun and Yang, Zhenming and Li, Liang and Zhang, Jiarui and Cao, Jing and Shao, Yue and Guo, Xinyue and Tian, Linli and Liu, Ming},
  title = {Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo},
  journal = {The International Journal of Biochemistry & Cell Biology},
  year = {2023},
  doi = {10.1016/j.biocel.2023.106398}
}
Kostenlos starten →